Literature DB >> 26893710

Targeting of NHERF1 through RNA interference inhibits the proliferation and migration of metastatic prostate cancer cells.

Qiang Ma1, Yanna Jiao2, Yumei Hao1, Shanshan Yan3, Nenan Lyu4, Honglin Gao1, Deguan Li1, Qiang Liu1, Junfang Zheng5, Naling Song1.   

Abstract

The present study aimed to investigate the effects of Na+/H+ exchanger regulatory factor 1 (NHERF1) gene knockdown, using short-hairpin RNA (shRNA), on the malignant behaviors of prostate cancer cells. A pSuper.puro NHERF1 shRNA vector was transfected into PC-3M prostate cancer cells using Lipofectamine 2000. Stable cell lines were obtained and NHERF1 knockdown was verified through western blot analysis. MTT assays were then used to measure PC-3M cell proliferation; in addition, cell migration was assessed using a wound healing assay. Flow cytometry was employed in order to determine the effects of NHERF1 knockdown on apoptosis. Expression levels of apoptotic pathway proteins B cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein were then determined by western blot analysis. The results demonstrated that shRNA knockdown of NHERF1 significantly suppressed the proliferation of PC-3M cells by >50%. In addition, knockdown of NHERF1 significantly inhibited the migration of PC-3M cells. PC-3M cells harboring NHERF1 shRNA exhibited significantly increased apoptosis, with an ~4-fold increase compared with that of the parental PC-3M cells and cells transfected with an empty vector. Furthermore, the results revealed that knockdown of NHERF1 reduced the protein expression of Bcl-2, although the expression of Bax was unaltered. In conclusion, NHERF1 knockdown using shRNA inhibited the proliferation and migration of PC-3M cells and promoted apoptosis, highlighting the role of NHERF1 in prostate cancer progression.

Entities:  

Keywords:  Na+/H+ exchanger regulatory factor 1; apoptosis; prostate cancer

Year:  2015        PMID: 26893710      PMCID: PMC4734028          DOI: 10.3892/ol.2015.4007

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  NHERF1/EBP50 in Breast Cancer: Clinical Perspectives.

Authors:  Antonia Bellizzi; Andrea Malfettone; Rosa A Cardone; Anita Mangia
Journal:  Breast Care (Basel)       Date:  2010-04-09       Impact factor: 2.860

2.  Expression and prognostic role of MEKK3 and pERK in patients with renal clear cell carcinoma.

Authors:  Qi Chen; Hong-sheng Lu; Mei-fu Gan; Lan-xi Chen; Kai He; Guang-min Fan; Xue-quan Cao
Journal:  Asian Pac J Cancer Prev       Date:  2015

3.  NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.

Authors:  Maria-Magdalena Georgescu; Gilbert Cote; Nitin Kumar Agarwal; Charles L White
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

4.  Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function.

Authors:  E L Kreimann; F C Morales; J de Orbeta-Cruz; Y Takahashi; H Adams; T-J Liu; P D McCrea; M-M Georgescu
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

5.  Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone.

Authors:  Martine P Roudier; Lawrence D True; Celestia S Higano; Hubert Vesselle; William Ellis; Paul Lange; Robert L Vessella
Journal:  Hum Pathol       Date:  2003-07       Impact factor: 3.466

6.  Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.

Authors:  Soulafa Mamlouk; Joanna Kalucka; Rashim Pal Singh; Kristin Franke; Antje Muschter; Anika Langer; Christiane Jakob; Max Gassmann; Gustavo B Baretton; Ben Wielockx
Journal:  Int J Cancer       Date:  2013-08-29       Impact factor: 7.396

7.  Crystallographic analysis of NHERF1-PLCβ3 interaction provides structural basis for CXCR2 signaling in pancreatic cancer.

Authors:  Yuanyuan Jiang; Shuo Wang; Joshua Holcomb; Laura Trescott; Xiaoqing Guan; Yuning Hou; Joseph Brunzelle; Nualpun Sirinupong; Chunying Li; Zhe Yang
Journal:  Biochem Biophys Res Commun       Date:  2014-03-15       Impact factor: 3.575

8.  A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration.

Authors:  Marianne F James; Roberta L Beauchamp; Nitasha Manchanda; Andrius Kazlauskas; Vijaya Ramesh
Journal:  J Cell Sci       Date:  2004-05-25       Impact factor: 5.285

9.  EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

Authors:  Wenfang Yao; Duiping Feng; Weihua Bian; Longyan Yang; Yang Li; Zhiyu Yang; Ying Xiong; Junfang Zheng; Renyou Zhai; Junqi He
Journal:  Amino Acids       Date:  2012-04-04       Impact factor: 3.520

Review 10.  Cancer-selective induction of apoptosis by leczyme.

Authors:  Takeo Tatsuta; Shigeki Sugawara; Kohta Takahashi; Yukiko Ogawa; Masahiro Hosono; Kazuo Nitta
Journal:  Front Oncol       Date:  2014-06-04       Impact factor: 6.244

View more
  3 in total

Review 1.  Circulating Tumor Cells: Does Ion Transport Contribute to Intravascular Survival, Adhesion, Extravasation, and Metastatic Organotropism?

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

2.  MINDIN Exerts Protumorigenic Actions on Primary Prostate Tumors via Downregulation of the Scaffold Protein NHERF-1.

Authors:  Luis Álvarez-Carrión; Irene Gutiérrez-Rojas; María Rosario Rodríguez-Ramos; Juan A Ardura; Verónica Alonso
Journal:  Cancers (Basel)       Date:  2021-01-24       Impact factor: 6.639

3.  Na+/H+ exchanger regulatory factor 1 overexpression suppresses the malignant phenotype of MIAPaCa-2 pancreatic adenocarcinoma cells by downregulating Akt phosphorylation.

Authors:  Xibo Zhang; Junjian Liu; Zhonglian Li
Journal:  Oncol Lett       Date:  2018-03-16       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.